Zobrazeno 1 - 10
of 54
pro vyhledávání: '"W F Riesen"'
Publikováno v:
DMW - Deutsche Medizinische Wochenschrift. 120:1109-1113
Statement of problem To analyse whether lipoprotein(a) is a risk factor for myocardial infarction, stroke and acute peripheral arterial occlusion in coronary heart disease and whether this risk can be assessed by clotting activation markers. Patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::22e2b7117a28c2c5d863fb5b85dc4176
https://doi.org/10.1055/s-2008-1055451
https://doi.org/10.1055/s-2008-1055451
Publikováno v:
Journal of Oncology Pharmacy Practice. 17:292-294
Aim: We report a case of bevacizumab-associated hyperlipoproteinemia in a patient with advanced breast cancer. Case summary: A 57-year-old woman with advanced invasive-ductal breast cancer was administered bevacizumab from March 2008 to February 2009
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee07e7eb41ba1e868a3ccbf6bc45ab1b
https://doi.org/10.1177/1078155210378912
https://doi.org/10.1177/1078155210378912
Publikováno v:
Oncology Research and Treatment. 19:126-131
The integrity of the skeleton is maintained by two tightly coupled processes: bone resorption and bone formation. Osteoclasts are responsible for bone degradation, osteoblasts for synthesis of the bon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2bb9d64657560d50f1a0ec058ef41084
https://doi.org/10.1159/000218778
https://doi.org/10.1159/000218778
Autor:
W F, Riesen
Publikováno v:
Praxis. 98(3)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::30d3df0ba23c79780498a6f3194b9a65
https://pubmed.ncbi.nlm.nih.gov/19291635
https://pubmed.ncbi.nlm.nih.gov/19291635
Autor:
W F, Riesen, R C, Mordasini
Publikováno v:
Praxis. 97(22)
Dyslipidemia is one of the most important cardiovascular risk factors. Accordingly preventive measures to normalize lipids are of great importance. The indication for a lipid lowering therapy according to current guidelines focuses on the identificat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::bb020078a605fc0c03919eb9b90049b6
https://pubmed.ncbi.nlm.nih.gov/18979436
https://pubmed.ncbi.nlm.nih.gov/18979436
Publikováno v:
Diabetic medicine : a journal of the British Diabetic Association. 14(7)
Fibrates and HMG CoA reductase inhibitors are commonly used in the treatment of diabetic dyslipidaemia. However, these two groups of drugs have not been compared in diabetic patients in a randomized controlled trial. Therefore, a multicentre study wa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f8941cfd85797f88a155ae3a8bdf59f6
https://pubmed.ncbi.nlm.nih.gov/9223386
https://pubmed.ncbi.nlm.nih.gov/9223386
Publikováno v:
Deutsche medizinische Wochenschrift (1946). 120(33)
To analyse whether lipoprotein(a) is a risk factor for myocardial infarction, stroke and acute peripheral arterial occlusion in coronary heart disease and whether this risk can be assessed by clotting activation markers.A partly prospective, partly r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::337c4677817397a3efcbbb74482629ac
https://pubmed.ncbi.nlm.nih.gov/8717204
https://pubmed.ncbi.nlm.nih.gov/8717204
Autor:
W F, Riesen
Publikováno v:
Journal of cardiovascular pharmacology. 25
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0d514e5dbc6772552db00af093e69cd0
https://pubmed.ncbi.nlm.nih.gov/9044998
https://pubmed.ncbi.nlm.nih.gov/9044998